Andere Sprachen Bio-Rad Laboratories, Inc.

Aktien

865406

US0905722072

BIO

Markt geschlossen - Nyse Andere Börsenplätze 22:00:02 29.04.2024			% 5 Tage	% 1. Jan.
277,1 ^USD	+0,42 %		-2,86 %	-14,18 %

29.04.	BIO-RAD LABORATORIES, INC. : Bewertung von RBC Capital Markets zum Kaufen erhalten	ZM
26.04.	Bio-Rad Laboratories, Inc. kündigt Änderungen bei Executive Vice President und President, Life Science Group an	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Bio-Rad Announces Life Science Group Management Changes	29.04.
Bio-Rad Announces Life Science Group Management Changes	26.04.
Bio-Rad Laboratories, Inc. Announces Executive Vice President and President Changes, Life Science Group	26.04.
Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024	18.04.
ONCOCYTE REPORTS FULL YEAR 2023 FINANCIAL RESULTS	15.04.
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay	11.04.
Oncocyte Corporation and Bio-Rad Laboratories, Inc. Partner on Global Launch of Transplant Assay	11.04.
Bio-Rad Laboratories COO Andrew Last to Retire in September	10.04.
Bio-Rad’s Chief Operating Officer Andrew Last to Retire	10.04.
Bio-Rad Laboratories, Inc. Announces Chief Operating Officer Andrew Last to Retire	10.04.
North American Morning Briefing : Focus Turns to -2-	04.04.
Biodesix Strikes New Research Deal With Memorial Sloan Kettering Cancer Center	25.03.
Bio-Rad Laboratories Appoints Roop Lakkaraju as CFO	20.03.
Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer	20.03.
Bio-Rad Laboratories, Inc. Appoints Roop K. Lakkaraju as Chief Financial Officer, Effective April 15, 2024	20.03.
Bio-Rad Laboratories, Inc. Appoints Roop K. Lakkaraju as New Executive Vice President Effective April 15, 2024	20.03.
Bio-rad Laboratories Insider Sold Shares Worth $1,008,000, According to a Recent SEC Filing	29.02.
Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day	22.02.
Bio Rad Labs rises after posting upbeat fourth-quarter profit	16.02.
Bio-Rad: Q4 Earnings Snapshot	15.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Bio-Rad Laboratories, Inc.

Aktien

865406

US0905722072

BIO

Andere Sprachen

Filter